These findings, along with the apparent curative effect seen when Δ32 homozygous hematopoietic stem cells were transplanted into a patient with AIDS and leukemia (the “Berlin patient” study) [28], have given great stimulus for the use of CCR5 blockers for inhibiting HIV-1 entry and infection. This evidence concerns the gene CCR5 and infection.